Trial Enrolling CF Patients With Digestive Enzyme Deficiency in Europe

Trial Enrolling CF Patients With Digestive Enzyme Deficiency in Europe

CF News Today's Daily Digest

Your Online Resource for the Latest CF News In the 10/16/2020 edition: Trial Enrolling Patients With Severe Digestive Enzyme Deficiency in Europe New Inhaled Therapy IONIS-ENAC-2.5Rx Shows Promise in Phase 1/2a Trial Trial Enrolling Patients With Severe Digestive Enzyme Deficiency in Europe By Patricia Inacio, PhD on Oct 16, 2020 07:00 am A Phase 2 clinical trial investigating MS1819 in combination with stable pancreatic enzyme replacement therapy (PERT) to treat exocrine pancreatic insufficiency (EPI) in people with cystic fibrosis (CF) is actively recruiting participants in Europe, AzurRx BioPharma, the treatment’s developer, announced. The open-label study (NCT04302662) expects to enroll 24 CF patients, ages 12 and older, with severe EPI who failed to respond fully to […] The post Trial Enrolling Patients With Severe Digestive Enzyme Deficiency in Europe appeared first on Cystic Fibrosis News Today. Continue reading New Inhaled Therapy IONIS-ENAC-2.5Rx Shows Promise in Phase 1/2a Trial By Teresa Carvalho on Oct 15, 2020 07:00 am Ionis Pharmaceuticals’ investigational inhaled therapy IONIS-ENAC-2.5Rx showed promise in a Phase 1/2a study as a potential new treatment for cystic fibrosis (CF), the company announced, citing trial data. That clinical data showed that ENAC-2.5Rx led to a reduction in the expression of ENaC, a sodium transport channel that’s highly increased in the lungs of people […] The post New Inhaled Therapy IONIS-ENAC-2.5Rx Shows Promise in Phase 1/2a Trial appeared first on Cystic Fibrosis News Today. Continue reading Recent Articles: Toronto Scientist Wins Award for Work Into Alternative Way of Treating CF If You’ve Lost Hope, Read This Trial of Oral CB-280 for Chronic Lung Infections in CF Enrolling Across US The ‘5-year Plan’ Is Not for the Chronically Ill Contemplating Our Identity